| Gemtuzumab ozogamicin - Wikipedia, the free encyclopedia Gemtuzumab ozogamicin (marketed by Wyeth as Mylotarg) is a drug-linked monoclonal antibody that was used to treat acute myelogenous leukemia from 2000-2010. It was ... Read More |
| Gemtuzumab: Information from Answers.com Gemtuzumab Key Terms: Antibody, Blasts, Calicheamicin, IgG, Humanization, Monoclonal. Definition Gemtuzumab ozogamicin is a humanized monoclonal antibody Read More |
| gemtuzumab medical facts from Drugs.com Physician reviewed gemtuzumab patient information - includes gemtuzumab description, dosage and directions. Read More |
| Gemtuzumab Ozogamicin - National Cancer Institute This page contains brief information about gemtuzumab ozogamicin and a collection of links to more information about the use of this drug, research results, and ... Read More |
| Gemtuzumab Voluntarily Withdrawn From US Market June 21, 2010 — Pfizer Inc has announced that it will be discontinuing commercial availability of gemtuzumab ozogamicin (Mylotarg; Wyeth) for the ... Read More |
| Mylotarg (gemtuzumab ozogamicin): Market Withdrawal Mylotarg (gemtuzumab ozogamicin): Market Withdrawal. Audience: Oncology, Hematology [Posted 06/21/2010] ISSUE: FDA notified healthcare professionals that results from ... Read More |
| Mylotarg (Gemtuzumab Ozogamicin for Injection) Drug Information ... Learn about the prescription medication Mylotarg (Gemtuzumab Ozogamicin for Injection), drug uses, dosage, side effects, drug interactions, warnings, reviews and ... Read More |
| Gemtuzumab Ozogamicin, Mylotarg - Chemotherapy Drugs, Chemo Drug ... Gemtuzumab ozogamicin is a monoclonal antibody. Mylotarg ... Print Chemotherapy Drugs Gemtuzumab ozogamicin. Gemtuzumab ozogamicin (gem-TOO-zoo-mab oh-zog-a-MY-sin) Read More |
| gemtuzumab | Cigna Before receiving gemtuzumab, tell your doctor if you have any type of infection, lung or breathing problems, liver or kidney disease, if you have ever received a stem ... Read More |
| Gemtuzumab Ozogamicin Injection: MedlinePlus Drug Information [Posted 06/21/2010] ISSUE: FDA notified healthcare professionals that results from a recent clinical trial raised new concerns about the product's safety ... Read More |
